Growth Hormone Treatment Does Not Affect Incidences of Middle Ear Disease or Hearing Loss in Infants and Toddlers with Turner Syndrome | Zendy

Marsha L. Davenport | Zendy; Jackson Roush | Zendy; Chun-Hua Liu | Zendy; Anthony J. Zagar | Zendy; Erica A. Eugster | Zendy; Sharon Travers | Zendy; Patricia Y. Fechner | Zendy; Charmian A. Quigley | Zendy

Open Access

Growth Hormone Treatment Does Not Affect Incidences of Middle Ear Disease or Hearing Loss in Infants and Toddlers with Turner Syndrome

Author(s) -

Marsha L. Davenport,

Jackson Roush,

Chun-Hua Liu,

Anthony J. Zagar,

Erica A. Eugster,

Sharon Travers,

Patricia Y. Fechner,

Charmian A. Quigley

Publication year - 2010

Publication title -

hormone research in paediatrics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.816

H-Index - 89

eISSN - 1663-2826

pISSN - 1663-2818

DOI - 10.1159/000313964

Subject(s) - medicine , pediatrics , tympanostomy tube , context (archaeology) , turner syndrome , hearing loss , randomized controlled trial , prospective cohort study , incidence (geometry) , otitis , surgery , audiology , paleontology , physics , optics , biology

No randomized, controlled, prospective study has evaluated the effect of growth hormone (GH) on the rates of middle ear (ME) disease and hearing loss in girls with Turner syndrome (TS).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research